knowledge -WSS

knowledge

author：entertainment 2025-09-03 05:31:34 - browse：4776

Feng Zhang Editas — Aera was formed to pursue a nanoparticle described by Feng Zhang in 2021. Susan Walsh/AP

Aera Therapeutics, a startup launched by the CRISPR pioneer Feng Zhang last year to solve one of the biggest bottlenecks in genetic medicine, has laid off a quarter of its staff, the company confirmed to STAT.

The layoffs come as the biotech market remains mired in a now nearly three-year-long downturn that has left startups struggling to attract both private and public funds. Aera attributed the layoffs to those headwinds and indicated it had axed a portion of the company dedicated to developing new gene-editing enzymes.

“In 2023, Aera launched to pursue an ambitious mission to develop transformative genetic medicines by harnessing enabling delivery technologies and precision payloads,” spokesman Dan Budwick said in a statement. “Although Aera remains in a strong cash position today, given the current biotech funding environment, we have chosen to take steps to focus our strategy and investments on the development of our novel delivery platforms, thereby further extending our cash runway.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： Senate panel passes drug pricing bills, but drops one PBM reform

WSS

Altering the blood type of lungs raises potential for universal organs for transplants

Flu, Covid vaccination rates decline, new survey data show

The Karikó problem: Lessons for funding basic research

Study points to new risk in gene therapy death of Terry Horgan

Nobel honors Karikó and Weissman's enduring partnership

IVG is promising — but it won’t replace IVF quite yet

explore

knowledge

knowledge

Activists slam private health insurers over coverage restrictions

FDA approves first new drug developed for postpartum depression

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Can medical device makers keep up in the race to treat obesity?

Tori Bowie and the unacceptable rates of Black maternal death

Science's Marcia McNutt, trailblazer for women, encounters sexism scandal

United colonoscopy coverage change 'may cost lives,' doctors say

Timeline: Key moments in fight for gay rights

Dobbs anniversary: the lost opportunity of abortion as health care

Setback for rare diseases as Taysha Gene Therapies pulls back

focus

Stop Congress from blocking public access to science

Altering the blood type of lungs raises potential for universal organs for transplants

Mom launches Girl Scout troop for LGBTQ youth in Texas

Science's Marcia McNutt, trailblazer for women, encounters sexism scandal

Nobel honors Karikó and Weissman's enduring partnership

We're not in Australia anymore: Kansas cops jump into action to save kangaroo

entertainment

focus

explore

entertainment